Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06738264

Cardiovascular Risk Factors in Rheumatoid Arthritis Patients ( Comparison Between Seronegative and Seropositive Cases )

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to learn about the long-term effects rheumatoid arthritis (RA) on cardiovascular system. The main question it aims to answer is: Does seropositive raise risk of cardiovascular diseases more than seronegative RA ?

Detailed description

We will investigate cardiovascular risk factors in patients with seronegative and seropositive rheumatoid arthritis. Complete clinical examination including blood pressure (BP; using an automatic BP monitor) and heart rate (in beats per minute (bpm) either from an automatic BP monitor or a 12 lead ECG) will be measured according to the standard hospital procedures. Routine Laboratory investigations, including complete blood count (CBC), Blood parameters, including autoantibodies and lipid profile will be determined), liver and kidney function tests, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and lipid profile panel will be recorded. The disease activity score-28 (DAS-28) and health assessment questionnaire (HAQ) will be assessed. Framingham risk score will be calculated. Carotid doppler will be done . Current medications use including synthetic disease-modifying anti-rheumatic drugs (DMARDs), in addition to steroids, will be recorded. Rheumatoid Factor and Anticitrullinated proteins antibodies presence will be determined. Cardiovascular risk factors, including inflammation, hypertension, smoking, obesity, and dyslipidemia will be observed and a higher risk of Cardiovascular Diseases events (including myocardial infarction, stroke, and heart failure).

Conditions

Timeline

Start date
2025-01-01
Primary completion
2025-09-01
Completion
2025-10-01
First posted
2024-12-17
Last updated
2024-12-17

Source: ClinicalTrials.gov record NCT06738264. Inclusion in this directory is not an endorsement.